Leveraging NMR and X-ray data of the free ligands to build better drugs targeting angiotensin II Type 1 G-Protein coupled receptor

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3022551 21 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Leveraging NMR and X-ray data of the free ligands to build better drugs targeting angiotensin II Type 1 G-Protein coupled receptor
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
The angiotensin II type 1 receptor (AT1R) has been recently crystallized. A new era has emerged for the structure-based rational drug design and the synthesis of novel AT1R antagonists. In this critical review, the X-ray crystallographic data of commercially available AT1R antagonists in free form are analyzed and compared with the conformational analysis results obtained using a combination of NMR spectroscopy and Molecular Modeling. The same AT1R antagonists are docked and compared in terms of their interactions in their binding site using homology models and the crystallized AT1R receptor. Various aspects derived from these comparisons regarding rational drug design are outlined. © 2016 Bentham Science Publishers.
Έτος δημοσίευσης:
2016
Συγγραφείς:
Kellici, T.F.
Ntountaniotis, D.
Kritsi, E.
Zervou, M.
Zoumpoulakis, P.
Potamitis, C.
Durdagi, S.
Salmas, R.E.
Ergun, G.
Gokdemir, E.
Halabalaki, M.
Gerothanassis, I.P.
Liapakis, G.
Tzakos, A.G.
Mavromoustakos, T.
Περιοδικό:
Current Medicinal Chemistry
Εκδότης:
Bentham Science Publishers
Τόμος:
23
Αριθμός / τεύχος:
1
Σελίδες:
36-59
Λέξεις-κλειδιά:
angiotensin 1 receptor; angiotensin 1 receptor antagonist; azilsartan; candesartan; candesartan hexetil; eprosartan; G protein coupled receptor; irbesartan; losartan; olmesartan; telmisartan; valsartan; angiotensin 1 receptor; angiotensin 1 receptor antagonist; ligand, Article; binding site; drug conformation; drug design; drug receptor binding; drug synthesis; drug targeting; human; hydrogen bond; lipid bilayer; molecular docking; molecular model; nuclear magnetic resonance spectroscopy; X ray crystallography; animal; chemistry; drug development; metabolism; nuclear magnetic resonance spectroscopy; procedures; X ray crystallography, Angiotensin II Type 1 Receptor Blockers; Animals; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Receptor, Angiotensin, Type 1
Επίσημο URL (Εκδότης):
DOI:
10.2174/0929867323666151117122116
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.